TITLE

Risk Factors for Massive Bleeding during Major Hepatectomy

AUTHOR(S)
Shirabe, Ken; Kajiyama, Kiyoshi; Harimoto, Norifumi; Tsujita, Eiji; Wakiyama, Shigeki; Maehara, Yoshihiko
PUB. DATE
July 2010
SOURCE
World Journal of Surgery;Jul2010, Vol. 34 Issue 7, p1555
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Massive bleeding during hepatectomy is a risk for mortality and morbidity. We examined the risk factors for massive bleeding and their correlations with outcomes. The study was a retrospective case series. Among 353 consecutively hepatectomized patients, the mean estimated blood loss (EBL) was 825 ml. Ten patients (2.8%) experienced EBL of between 3000 and 5000 ml. Five patients (1.4%) experienced massive EBL defined as more than 5000 ml, and all five patients had undergone right major hepatectomy (RMH) for primary liver cancer (PLC). All the patients with PLC who underwent RMH were divided into two groups: group I with EBL ≤ 5000 ml ( n = 19) and group II with EBL > 5000 ml ( n = 5). Perioperative factors regarding massive bleeding and operative mortality and morbidity were compared between the two groups. Among the ten patients who experienced EBL of between 3000 and 5000 ml, three had partial hepatectomy of no more than subsegmentectomy of the paracaval portion of the caudate lobe and three had central bisegmentectomy. The mean tumor size was 7.9 ± 4.7 cm in group I and 15.1 ± 2.2 cm in group II ( P = 0 .0034). Tumor compression of the inferior vena cava (IVC) on CT scans was observed in all patients in group II, but in no patients in group I ( P < 0.0001). Four of five patients in group II received surgery through an anterior approach. The liver-hanging maneuver (LHM) was applied in 14 of 19 patients (74%) in group I but could not be applied in group II ( P = 0.0059). No postoperative and in-hospital mortalities occurred in group II and there were no significant differences in the incidence of mortality and morbidity between the groups. RMH for large PLCs, tumor compression of the IVC, and an anterior approach without the LHM are risks for massive bleeding during hepatectomy. Preparation of rapid infusion devices in these cases is necessary to avoid prolonged hypotension.
ACCESSION #
51880577

 

Related Articles

  • Lesser sac hematoma as a sign of rupture of hepatocellular carcinoma in the caudate lobe. Iwasaki, Yoshie; Tani, Ichiro; Nakajima, Yasuo; Ishikawa, Tohru; Umeda, Satoshi; Kusano, Shoichi // European Radiology;Mar2001, Vol. 11 Issue 3, p422 

    The purpose of this study was to evaluate the CT findings of rupture of hepatocellular carcinoma (HCC) in the caudate lobe of the liver. The CT scans of five cases of rupture of HCC in the caudate lobe of the liver were retrospectively reviewed and correlated with clinical records. All cases...

  • Prognostic Factors after Resection for Hepatocellular Carcinoma in Noncirrhotic Livers: Univariate and Multivariate Analysis World J. Surg. Vol. 27, No. 4, April 2003. Chen, Miin-Fu; Tsai, Hsiu-Pei; Jeng, Long-Bin; Lee, Wei-Chen; Yeh, Chun-Nan; Yu, Ming-Chin; Hung, Chao-Ming // World Journal of Surgery;Apr2003, Vol. 27 Issue 4, p443 

    The aim of this study was to investigate the prognostic factors for hepatocellular carcinoma (HCC) in patients without cirrhosis who underwent hepatectomy. Between 1986 and 1998 a total of 197 men and 57 women with noncirrhotic HCC underwent hepatic resection in the Department of Surgery, Chang...

  • Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy? Yamashita, Tatsuya // Journal of Gastroenterology;2004, Vol. 39 Issue 4, p404 

    Despite marked advances in the treatment of hepatocellular carcinoma such as hepatectomy, liver transplantation, percutaneous ethanol injection therapy, percutaneous radiofrequency ablation therapy, and transcatheter arterial embolization therapy, these therapies are frequently followed by...

  • Delayed versus emergency hepatectomy for ruptured hepatocellular carcinoma. Anon, Chotirosniramit // Indian Journal of Surgery;Aug2006, Vol. 68 Issue 4, p209 

    Background and Aims: Ruptured hepatocellular carcinoma (HCC) is a life-threatening complication of HCC. Delayed hepatectomy after successful hemostasis or emergency hepatectomy is the controversial issue of the treatment for resectable ruptured HCC. The aim of this study was to evaluate outcomes...

  • Surgical treatment of childhood hepatoblastoma in the Netherlands (1990-2013). Busweiler, Linde; Wijnen, Marc; Wilde, Jim; Sieders, Egbert; Terwisscha van Scheltinga, Sheila; Heurn, L.; Ziros, Joseph; Bakx, Roel; Heij, Hugo.; Busweiler, Linde A D; Wijnen, Marc H W A; Wilde, Jim C H; Terwisscha van Scheltinga, Sheila E J; van Heurn, L W Ernest; Heij, Hugo A // Pediatric Surgery International;Jan2017, Vol. 33 Issue 1, p23 

    Background: Achievement of complete surgical resection plays a key role in the successful treatment of children with hepatoblastoma. The aim of this study is to assess the surgical outcomes after partial liver resections for hepatoblastoma, focusing on postoperative complications,...

  • Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy. Motomura, Takashi; Ono, Yuki; Shirabe, Ken; Fukuhara, Takasuke; Konishi, Hideyuki; Mano, Yohei; Toshima, Takeo; Yoshiya, Shohei; Muto, Jun; Ikegami, Toru; Yoshizumi, Tomoharu; Maehara, Yoshihiko // HPB Surgery;2012, Special section p1 

    Purpose. Genetic polymorphisms of MICA and DEPDC5 have been reported to correlate with progression to hepatocellular carcinoma (HCC) in chronic hepatitis C patients. However, correlation of these genetic variants with HCC recurrence following hepatectomy has not yet been clarified. Methods....

  • Impact of the Thoracoabdominal Approach on Peri- and Postoperative Outcomes of Hepatectomy for Hepatocellular Carcinoma. Okamura, Yukiyasu; Takeda, Shin; Fujii, Tsutomu; Sugimoto, Hiroyuki; Nomoto, Shuji; Nakao, Akimasa // World Journal of Surgery;May2011, Vol. 35 Issue 5, p1042 

    Background: Resection of hepatocellular carcinoma (HCC) located in the right liver often requires hepatic mobilization. However, exposure of the HCC may be restricted when using the conventional abdominal approach (AA). In such cases, a thoracoabdominal approach (TA) can provide a good operating...

  • Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients. Xiao-Ping Chen; Fa-Zu Qiu; Wan-Yee Lau; Bi-Xiang Zhang; Yi-Fa Chen; Wan-Guang Zhang; Song-Qing He // International Journal of Colorectal Disease;May2008, Vol. 23 Issue 5, p543 

    Mesohepatectomy is a rarely used operative procedure to treat liver cancer because of its technical complexity. In patients with hepatocellular carcinoma (HCC) with a viral hepatitic/cirrhotic background, this procedure can be used to resect the tumor with adequate margins, while at the same...

  • Susceptibility-Weighted Imaging for the Noncontrast Evaluation of Hepatocellular Carcinoma: A Prospective Study with Histopathologic Correlation. Chen, Wei; DelProposto, Zachary; Liu, Wei; Kassir, Mohammad; Wang, Zhiyuan; Zhao, Jun; Xie, Bing; Wen, Yaming; Wang, Jian; Hu, Jiani // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: Specific morphologic features of hepatocellular carcinoma (HCC) on imaging have identifiable pathologic correlates as well as implications for altering surgical management and defining prognosis. In this study, we compared susceptibility-weighted imaging (SWI) to conventional...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics